This trial is testing a new drug to see if it is safe and tolerated by adults. They will also be trying to determine the highest dose of the drug that can be given without causing serious side effects.
8 Primary · 19 Secondary · Reporting Duration: Year 1, 2, and 3
Experimental Treatment
459 Total Participants · 7 Treatment Groups
Primary Treatment: AMG 509 · No Placebo Group · Phase 1
Age 18+ · Male Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: